Picard Medical, Inc. 8-K

What Happened

• On March 19, 2026, Picard Medical, Inc. filed an 8-K under Regulation FD to furnish a press release announcing that a patient was sustained for 119 days by the SynCardia Total Artificial Heart (TAH) while waiting for a donor transplant. The press release is furnished as Exhibit 99.1 to the filing.

Key Details

• Filing date: March 19, 2026 (Item 7.01 Regulation FD Disclosure).
• Device referenced: SynCardia Total Artificial Heart (TAH).
• Clinical detail: patient sustained for 119 days while awaiting donor transplant.
• The press release was furnished (not “filed”) and is included as Exhibit 99.1.

Why It Matters

• This is a clinical update confirming a real-world use of Picard’s SynCardia TAH as a bridge to transplant for an extended period (119 days). For investors, such disclosures can inform perceptions about the device’s clinical durability and ongoing patient need.
• The company used a Regulation FD disclosure to ensure the information was broadly shared with the public; no financial results or forward-looking business decisions were reported in this filing.